LDL-C Monitoring Frequency After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease

被引：0
|
作者：
Cohen, Sarah S.
Chamberlain, Alanna M.
Killian, Jill M.
Monda, Keri L.
Weston, Susan A.
Okerson, Ted
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Statins; LDL; Epidemiology; Diabetes; Mellitus; Cardiovascular disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15727
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The ApoB/LDL-C Ratio Predicts Cardiovascular Events in Coronary Artery Disease Patients Independent of Type 2 Diabetes Status
    Larcher, Barbara
    Plattner, Thomas
    Mader, Arthur
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2024, 73
  • [32] The ApoB/LDL-C Ratio Predicts Cardiovascular Events in Coronary Artery Disease Patients Independently of Type 2 Diabetes Status
    Larcher, Barbara
    Plattner, Thomas
    Mader, Arthur
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    CIRCULATION, 2024, 150
  • [33] Ezetimibe Use and LDL-C Goal Achievement: A Retrospective Database Analysis of Patients with Clinical Atherosclerotic Cardiovascular Disease or Probable Heterozygous Familial Hypercholesterolemia
    Menzin, Joseph
    Aggarwal, Jyoti
    Boatman, Brian
    Yu, Jeffrey
    Stern, Kevin
    Harrison, David J.
    Patel, Jeetvan G.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (12): : 1270 - +
  • [34] Effects of Serum LDL-C, CysC, and D-D in Patients with Coronary Atherosclerotic Heart Disease
    Shen, Chaofeng
    Wang, Jing
    Tu, Sijia
    COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE, 2022, 2022
  • [35] The ApoB/LDL-C ratio predicts cardiovascular events in coronary artery disease patients independent of type 2 diabetes status
    Larcher, B.
    Plattner, T.
    Mader, A.
    Vonbank, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [36] The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL
    Li, Chuang
    Chen, Qiwen
    Zhang, Mei
    Liu, Yin
    Chu, Yushun
    Meng, Fanpeng
    Wang, Jianyu
    Tang, Jie
    Luo, Jian
    Niu, Xiulong
    Wei, Maoti
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [37] Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
    Mackinnon, Erin S.
    Leiter, Lawrence A.
    Wani, Rajvi J.
    Burke, Natasha
    Shaw, Eileen
    Witges, Kelcie
    Goodman, Shaun G.
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 205 - 220
  • [38] Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
    Erin S. Mackinnon
    Lawrence A. Leiter
    Rajvi J. Wani
    Natasha Burke
    Eileen Shaw
    Kelcie Witges
    Shaun G. Goodman
    Cardiology and Therapy, 2024, 13 : 205 - 220
  • [39] Choice of Statins in Lowering the Cardiovascular Risk According to the LDL-C Levels after Dietary Control
    Ho, S. C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S31 - S31
  • [40] Relationship Between LDL-C Reduction After Coronary Revascularization and Prevention of Recurrent Cardiovascular Events
    Nishiwaki, Tatsuhiro
    Kishi, Daisuke
    Yoshie, Fumihiko
    Fukuda, Keiko
    Ibuki, Chikao
    Seino, Yoshihiko
    Satoh, Mitsutoshi
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2010, 13 (02): : 254 - 262
12345